121 related articles for article (PubMed ID: 17622766)
1. Induction of apoptosis and inhibition of cell migration and tube-like formation by dihydroartemisinin in murine lymphatic endothelial cells.
Wang J; Guo Y; Zhang BC; Chen ZT; Gao JF
Pharmacology; 2007; 80(4):207-18. PubMed ID: 17622766
[TBL] [Abstract][Full Text] [Related]
2. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression.
Zhou HJ; Wang Z; Li A
Anticancer Drugs; 2008 Mar; 19(3):247-55. PubMed ID: 18510170
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis of human umbilical vein endothelial cells induced by artesunate.
Wu GD; Zhou HJ; Wu XH
Vascul Pharmacol; 2004 Jul; 41(6):205-12. PubMed ID: 15653096
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2.
Hu CJ; Zhou L; Cai Y
Cancer Biol Ther; 2014 Mar; 15(3):279-88. PubMed ID: 24335512
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
Dong F; Zhou X; Li C; Yan S; Deng X; Cao Z; Li L; Tang B; Allen TD; Liu J
Cancer Biol Ther; 2014; 15(11):1479-88. PubMed ID: 25482945
[TBL] [Abstract][Full Text] [Related]
7. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway.
Liu Y; Gao S; Zhu J; Zheng Y; Zhang H; Sun H
Cancer Med; 2018 Nov; 7(11):5704-5715. PubMed ID: 30338663
[TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo.
Chen H; Sun B; Pan S; Jiang H; Sun X
Anticancer Drugs; 2009 Feb; 20(2):131-40. PubMed ID: 19209030
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro.
Zhou HJ; Zhang JL; Li A; Wang Z; Lou XE
Cancer Chemother Pharmacol; 2010 May; 66(1):21-9. PubMed ID: 19756601
[TBL] [Abstract][Full Text] [Related]
11. Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells.
Mu D; Chen W; Yu B; Zhang C; Zhang Y; Qi H
Methods Find Exp Clin Pharmacol; 2007; 29(1):33-8. PubMed ID: 17344942
[TBL] [Abstract][Full Text] [Related]
12. The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells.
Mu D; Zhang W; Chu D; Liu T; Xie Y; Fu E; Jin F
Cancer Chemother Pharmacol; 2008 Apr; 61(4):639-45. PubMed ID: 17609948
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the mitochondrial pathway and Bim/Bcl-2 balance in dihydroartemisinin-induced apoptosis in human breast cancer in vitro.
Mao H; Gu H; Qu X; Sun J; Song B; Gao W; Liu J; Shao Q
Int J Mol Med; 2013 Jan; 31(1):213-8. PubMed ID: 23138847
[TBL] [Abstract][Full Text] [Related]
14. Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo.
Zhang CZ; Zhang H; Yun J; Chen GG; Lai PB
Biochem Pharmacol; 2012 May; 83(9):1278-89. PubMed ID: 22342732
[TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells.
Lee J; Zhou HJ; Wu XH
Cancer Chemother Pharmacol; 2006 Jan; 57(2):213-20. PubMed ID: 16075280
[TBL] [Abstract][Full Text] [Related]
16. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
Li Y; Zhou X; Liu J; Gao N; Yang R; Wang Q; Ji J; Ma L; He Q
Life Sci; 2020 May; 248():117454. PubMed ID: 32088211
[TBL] [Abstract][Full Text] [Related]
17. Anti-hypoxic effect of dihydroartemisinin on pulmonary artery endothelial cells.
Yu H; Liu J; Dong Y; Xu M; Xu L; Guan H; Xia X; Wang L
Biochem Biophys Res Commun; 2018 Dec; 506(4):840-846. PubMed ID: 30391003
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
Chen HH; Zhou HJ; Wu GD; Lou XE
Pharmacology; 2004 May; 71(1):1-9. PubMed ID: 15051917
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial dihydroartemisinin also inhibits angiogenesis.
Chen HH; Zhou HJ; Wang WQ; Wu GD
Cancer Chemother Pharmacol; 2004 May; 53(5):423-32. PubMed ID: 15132130
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
